AP MOLLER-MAERSK A/S-B (DP4B.DE) Fundamental Analysis & Valuation

Name: AP MOLLER-MAERSK A/S-B (DP4B.DE) Fundamental Analysis Rating
Brand: AP MOLLER-MAERSK A/S-B

FRA:DP4B • DK0010244508

2137 EUR

-15 (-0.7%)

Last: Mar 30, 2026, 07:00 PM

This DP4B.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. DP4B.DE Profitability Analysis

1.1 Basic Checks

DP4B had positive earnings in the past year.
In the past year DP4B had a positive cash flow from operations.
Each year in the past 5 years DP4B has been profitable.
DP4B had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of 3.08%, DP4B is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
With a Return On Equity value of 4.90%, DP4B is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
DP4B's Return On Invested Capital of 3.39% is on the low side compared to the rest of the industry. DP4B is outperformed by 64.71% of its industry peers.
DP4B had an Average Return On Invested Capital over the past 3 years of 4.88%. This is below the industry average of 8.71%.

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROIC	3.39%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

1.3 Margins

DP4B has a Profit Margin of 5.05%. This is in the lower half of the industry: DP4B underperforms 76.47% of its industry peers.
DP4B's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 5.30%, DP4B is doing worse than 70.59% of the companies in the same industry.
DP4B's Operating Margin has declined in the last couple of years.
DP4B has a worse Gross Margin (21.21%) than 76.47% of its industry peers.
DP4B's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	5.3%
PM (TTM)	5.05%
GM	21.21%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. DP4B.DE Health Analysis

2.1 Basic Checks

DP4B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, DP4B has less shares outstanding
DP4B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DP4B has a worse debt to assets ratio.

2.2 Solvency

DP4B has an Altman-Z score of 2.49. This is not the best score and indicates that DP4B is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.49, DP4B perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
The Debt to FCF ratio of DP4B is 3.81, which is a good value as it means it would take DP4B, 3.81 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.81, DP4B is in line with its industry, outperforming 58.82% of the companies in the same industry.
DP4B has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
DP4B has a better Debt to Equity ratio (0.27) than 76.47% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Altman-Z	2.49

ROIC/WACC0.47

WACC7.16%

2.3 Liquidity

A Current Ratio of 2.12 indicates that DP4B has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.12, DP4B is doing good in the industry, outperforming 76.47% of the companies in the same industry.
DP4B has a Quick Ratio of 2.02. This indicates that DP4B is financially healthy and has no problem in meeting its short term obligations.
DP4B has a better Quick ratio (2.02) than 76.47% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.12
Quick Ratio	2.02

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. DP4B.DE Growth Analysis

3.1 Past

The earnings per share for DP4B have decreased strongly by -54.45% in the last year.
DP4B shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.98% yearly.
Looking at the last year, DP4B shows a decrease in Revenue. The Revenue has decreased by -2.69% in the last year.
Measured over the past years, DP4B shows a small growth in Revenue. The Revenue has been growing by 6.32% on average per year.

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

3.2 Future

The Earnings Per Share is expected to decrease by -5.51% on average over the next years.
DP4B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.54% yearly.

EPS Next Y-104.3%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

EPS Next 5Y-5.51%

Revenue Next Year-5.86%

Revenue Next 2Y-2.12%

Revenue Next 3Y0.01%

Revenue Next 5Y2.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks Show best growing peers

4. DP4B.DE Valuation Analysis

4.1 Price/Earnings Ratio

DP4B is valuated correctly with a Price/Earnings ratio of 13.92.
Based on the Price/Earnings ratio, DP4B is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 25.35. DP4B is valued slightly cheaper when compared to this.
DP4B is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	13.92
Fwd PE	N/A

4.2 Price Multiples

76.47% of the companies in the same industry are more expensive than DP4B, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DP4B is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	7.83
EV/EBITDA	4.87

4.3 Compensation for Growth

DP4B's earnings are expected to decrease with -69.32% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)3.49

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. DP4B.DE Dividend Analysis

5.1 Amount

DP4B has a Yearly Dividend Yield of 2.93%.
DP4B's Dividend Yield is slightly below the industry average, which is at 5.80.
Compared to an average S&P500 Dividend Yield of 1.89, DP4B pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	2.93%

5.2 History

The dividend of DP4B is nicely growing with an annual growth rate of 50.43%!

Dividend Growth(5Y)50.43%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

DP4B pays out 93.47% of its income as dividend. This is not a sustainable payout ratio.
DP4B's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.

DP93.47%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

More info and screens

Find the best dividend stocks Show peers with best dividend

DP4B.DE Fundamentals: All Metrics, Ratios and Statistics

AP MOLLER-MAERSK A/S-B

FRA:DP4B (3/30/2026, 7:00:00 PM)

2137

-15 (-0.7%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupTransportation

GICS IndustryMarine Transportation

Earnings (Last)02-05 2026-02-05/bmo

Earnings (Next)05-08 2026-05-08/bmo

Inst Owners21.14%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap33.83B

Revenue(TTM)53.99B

Net Income(TTM)2.73B

Analysts38.82

Price Target1733.41 (-18.89%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.93%

Yearly Dividend145.61

Dividend Growth(5Y)50.43%

DP93.47%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-63.1%

Min EPS beat(2)-129.84%

Max EPS beat(2)3.65%

EPS beat(4)2

Avg EPS beat(4)-23.23%

Min EPS beat(4)-129.84%

Max EPS beat(4)33.56%

EPS beat(8)5

Avg EPS beat(8)26.48%

EPS beat(12)9

Avg EPS beat(12)31.84%

EPS beat(16)11

Avg EPS beat(16)25.48%

Revenue beat(2)2

Avg Revenue beat(2)0.51%

Min Revenue beat(2)0.38%

Max Revenue beat(2)0.65%

Revenue beat(4)3

Avg Revenue beat(4)0.35%

Min Revenue beat(4)-1.86%

Max Revenue beat(4)2.23%

Revenue beat(8)5

Avg Revenue beat(8)0.16%

Revenue beat(12)5

Avg Revenue beat(12)-1.44%

Revenue beat(16)7

Avg Revenue beat(16)-1.28%

PT rev (1m)3.48%

PT rev (3m)5.25%

EPS NQ rev (1m)-2963.92%

EPS NQ rev (3m)45.52%

EPS NY rev (1m)-338.43%

EPS NY rev (3m)-161.01%

Revenue NQ rev (1m)0.15%

Revenue NQ rev (3m)4.08%

Revenue NY rev (1m)0.11%

Revenue NY rev (3m)-0.06%

Valuation

		Industry Rank	Sector Rank
PE	13.92
Fwd PE	N/A
P/S	0.72
P/FCF	7.83
P/OCF	3.98
P/B	0.7
P/tB	0.86
EV/EBITDA	4.87

EPS(TTM)153.5

EY7.18%

EPS(NY)-6.6

Fwd EYN/A

FCF(TTM)272.95

FCFY12.77%

OCF(TTM)536.93

OCFY25.13%

SpS2969.77

BVpS3057.4

TBVpS2484.22

PEG (NY)N/A

PEG (5Y)3.49

Graham Number3249.54

Profitability

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROCE	3.87%
ROIC	3.39%
ROICexc	3.94%
ROICexgc	4.72%
OM	5.3%
PM (TTM)	5.05%
GM	21.21%
FCFM	9.19%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

ROICexc(3y)5.5%

ROICexc(5y)18.16%

ROICexgc(3y)6.52%

ROICexgc(5y)21.16%

ROCE(3y)5.56%

ROCE(5y)17.48%

ROICexgc growth 3Y-53.48%

ROICexgc growth 5Y-13.27%

ROICexc growth 3Y-53.64%

ROICexc growth 5Y-13.99%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

F-Score4

Asset Turnover0.61

Health

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Debt/EBITDA	1.55
Cap/Depr	72.37%
Cap/Sales	8.89%
Interest Coverage	2.83
Cash Conversion	102.86%
Profit Quality	182.09%
Current Ratio	2.12
Quick Ratio	2.02
Altman-Z	2.49

F-Score4

WACC7.16%

ROIC/WACC0.47

Cap/Depr(3y)66.27%

Cap/Depr(5y)66.65%

Cap/Sales(3y)7.87%

Cap/Sales(5y)6.7%

Profit Quality(3y)151.91%

Profit Quality(5y)133.11%

High Growth Momentum

Growth

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

EPS Next Y-104.3%

EPS Next 2Y-46.39%

EPS Next 3Y-69.32%

EPS Next 5Y-5.51%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

Revenue Next Year-5.86%

Revenue Next 2Y-2.12%

Revenue Next 3Y0.01%

Revenue Next 5Y2.54%

EBIT growth 1Y-51.61%

EBIT growth 3Y-54.96%

EBIT growth 5Y-5.73%

EBIT Next Year95.06%

EBIT Next 3Y30%

EBIT Next 5Y29.47%

FCF growth 1Y-31.15%

FCF growth 3Y-45.3%

FCF growth 5Y-5.27%

OCF growth 1Y-14.44%

OCF growth 3Y-34.34%

OCF growth 5Y4.51%

AP MOLLER-MAERSK A/S-B / DP4B.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a fundamental rating of 3 / 10 to DP4B.DE.

Can you provide the valuation status for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a valuation rating of 2 / 10 to AP MOLLER-MAERSK A/S-B (DP4B.DE). This can be considered as Overvalued.

What is the profitability of DP4B stock?

AP MOLLER-MAERSK A/S-B (DP4B.DE) has a profitability rating of 2 / 10.

What are the PE and PB ratios of AP MOLLER-MAERSK A/S-B (DP4B.DE) stock?

The Price/Earnings (PE) ratio for AP MOLLER-MAERSK A/S-B (DP4B.DE) is 13.92 and the Price/Book (PB) ratio is 0.7.

How financially healthy is AP MOLLER-MAERSK A/S-B?

The financial health rating of AP MOLLER-MAERSK A/S-B (DP4B.DE) is 6 / 10.